HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
about
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@en
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@nl
type
label
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@en
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@nl
prefLabel
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@en
HLJ1 is an endogenous Src inhi ...... ssion through dual mechanisms.
@nl
P2093
P2860
P356
P1433
P1476
HLJ1 is an endogenous Src inhi ...... ession through dual mechanisms
@en
P2093
J J W Chen
P2860
P2888
P304
P356
10.1038/ONC.2016.106
P407
P577
2016-04-11T00:00:00Z